Literature DB >> 15571448

Injectable cartilage tissue engineering.

Jennifer Elisseeff1.   

Abstract

Cartilage is the tissue that lines the surface of bones in articulating joints, allowing painless joint movement. Cartilage loss is an increasingly significant problem, particularly with the ageing of active baby boomers, with few efficacious treatments available at present. Tissue engineering is a field that has evolved over recent years to combat tissue loss by providing a living tissue equivalent or substitute that can mimic the properties of the lost tissue. The general strategy of tissue engineering is to place cells on a biomaterial scaffold that is designed to promote cell function and form new tissue. This review describes the status of materials that are available as injectable scaffolds for tissue engineering and the numerous cell types that can be applied to cartilage repair, including cells derived from cartilage and stem cells. The current state of injectable cartilage tissue engineering and the hurdles that remain for widespread clinical application are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571448     DOI: 10.1517/14712598.4.12.1849

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  24 in total

1.  Thermoresponsive hyperbranched copolymer with multi acrylate functionality for in situ cross-linkable hyaluronic acid composite semi-IPN hydrogel.

Authors:  Yixiao Dong; Waqar Hassan; Yu Zheng; Aram Omer Saeed; Hongliang Cao; Hongyun Tai; Abhay Pandit; Wenxin Wang
Journal:  J Mater Sci Mater Med       Date:  2011-12-06       Impact factor: 3.896

Review 2.  Custom design of the cardiac microenvironment with biomaterials.

Authors:  Michael E Davis; Patrick C H Hsieh; Alan J Grodzinsky; Richard T Lee
Journal:  Circ Res       Date:  2005-07-08       Impact factor: 17.367

Review 3.  Inductive tissue engineering with protein and DNA-releasing scaffolds.

Authors:  David M Salvay; Lonnie D Shea
Journal:  Mol Biosyst       Date:  2005-11-25

4.  Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells.

Authors:  Lisa Haines-Butterick; Karthikan Rajagopal; Monica Branco; Daphne Salick; Ronak Rughani; Matthew Pilarz; Matthew S Lamm; Darrin J Pochan; Joel P Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

5.  Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold.

Authors:  Sotirios Koutsopoulos; Larry D Unsworth; Yusuke Nagai; Shuguang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

6.  Magnetic resonance imaging of chondrocytes labeled with superparamagnetic iron oxide nanoparticles in tissue-engineered cartilage.

Authors:  Sharan Ramaswamy; Jane B Greco; Mehmet C Uluer; Zijun Zhang; Zhuoli Zhang; Kenneth W Fishbein; Richard G Spencer
Journal:  Tissue Eng Part A       Date:  2009-12       Impact factor: 3.845

7.  Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery.

Authors:  Neda Habibi; Nazila Kamaly; Adnan Memic; Hadi Shafiee
Journal:  Nano Today       Date:  2016-02       Impact factor: 20.722

8.  Human umbilical cord stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue engineering.

Authors:  Jun Liu; Hockin H K Xu; Hongzhi Zhou; Michael D Weir; Qianming Chen; Carroll Ann Trotman
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

9.  Tensile properties of engineered cartilage formed from chondrocyte- and MSC-laden hydrogels.

Authors:  A H Huang; M Yeger-McKeever; A Stein; R L Mauck
Journal:  Osteoarthritis Cartilage       Date:  2008-03-18       Impact factor: 6.576

10.  Noninvasive assessment of glycosaminoglycan production in injectable tissue-engineered cartilage constructs using magnetic resonance imaging.

Authors:  Sharan Ramaswamy; Mehmet C Uluer; Stephanie Leen; Preeti Bajaj; Kenneth W Fishbein; Richard G Spencer
Journal:  Tissue Eng Part C Methods       Date:  2008-09       Impact factor: 3.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.